274 related articles for article (PubMed ID: 21852546)
1. Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
Harro C; Chakraborty S; Feller A; DeNearing B; Cage A; Ram M; Lundgren A; Svennerholm AM; Bourgeois AL; Walker RI; Sack DA
Clin Vaccine Immunol; 2011 Oct; 18(10):1719-27. PubMed ID: 21852546
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
3. Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.
Chakraborty S; Harro C; DeNearing B; Brubaker J; Connor S; Maier N; Dally L; Flores J; Bourgeois AL; Walker R; Sack DA
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006442. PubMed ID: 29702652
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
5. Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic
Rollenhagen JE; Jones F; Hall E; Maves R; Nunez G; Espinoza N; O'Dowd A; Prouty MG; Savarino SJ
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510102
[TBL] [Abstract][Full Text] [Related]
6. Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
Talaat KR; Porter CK; Jaep KM; Duplessis CA; Gutierrez RL; Maciel M; Adjoodani B; Feijoo B; Chakraborty S; Brubaker J; Trop SA; Riddle MS; Joseph SS; Bourgeois AL; Prouty MG
PLoS One; 2020; 15(12):e0239888. PubMed ID: 33264302
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
8. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.
Darsley MJ; Chakraborty S; DeNearing B; Sack DA; Feller A; Buchwaldt C; Bourgeois AL; Walker R; Harro CD
Clin Vaccine Immunol; 2012 Dec; 19(12):1921-31. PubMed ID: 23035175
[TBL] [Abstract][Full Text] [Related]
9. The immune response of pregnant sow after vaccination with crude fimbriae (F4) extracts vaccine and immunoprotection of nursery pig against pathogenic E. coli (F4
Nguyet LTY; Ounjai P; Ngamwongsatit N; Kaeoket K
Acta Trop; 2024 Jun; 254():107173. PubMed ID: 38503364
[TBL] [Abstract][Full Text] [Related]
10. Intramuscularly Administered Enterotoxigenic
Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
12. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
[TBL] [Abstract][Full Text] [Related]
14. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
15. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
[TBL] [Abstract][Full Text] [Related]
16. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.
Coster TS; Wolf MK; Hall ER; Cassels FJ; Taylor DN; Liu CT; Trespalacios FC; DeLorimier A; Angleberger DR; McQueen CE
Infect Immun; 2007 Jan; 75(1):252-9. PubMed ID: 17074855
[TBL] [Abstract][Full Text] [Related]
17. Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTa
Nandre RM; Duan Q; Wang Y; Zhang W
Vaccine; 2017 Jan; 35(4):552-556. PubMed ID: 28017433
[TBL] [Abstract][Full Text] [Related]
18. Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A.
Byrd W; Mog SR; Cassels FJ
Infect Immun; 2003 Jan; 71(1):13-21. PubMed ID: 12496144
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.
O'Dowd A; Maciel M; Poole ST; Jobling MG; Rollenhagen JE; Woods CM; Sincock SA; McVeigh AL; Gregory MJ; Maves RC; Prouty MG; Holmes RK; Savarino SJ
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839188
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC).
Porter CK; Riddle MS; Tribble DR; Louis Bougeois A; McKenzie R; Isidean SD; Sebeny P; Savarino SJ
Vaccine; 2011 Aug; 29(35):5869-85. PubMed ID: 21616116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
